For example, central administration of TNF-α at low dose can mimic the effect of obesity-related inflammatory milieu to activate IKKβ/NF-κB proinflammatory pathways, furthering the development of overeating, energy expenditure decrease, and weight gain [34;159]. Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.